Evidence map›Paper›PMID 31172215›Full record

ReviewCellular and molecular life sciences : CMLS2019

MMPs in learning and memory and neuropsychiatric disorders.

Anna Beroun, Shiladitya Mitra, Piotr Michaluk, Barbara Pijet, Marzena Stefaniuk, Leszek Kaczmarek

Open access · hybridAbstract readReview
In one paragraph

Review in Cellular and molecular life sciences : CMLS, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 113 papers, 2 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
113citing papers in PubMed, 2 pooled it
11.4field-weighted citation impact, top 1% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

113 citing papers in PubMed, 2 syntheses or guidelines pooled it, 203 citations in OpenAlex.

  1. Pooled it
  2. Pooled it
  3. Trial
  4. Trial
  5. Trial
  6. Trial
  7. Trial
  8. Article
  9. Article
  10. Article
  11. Article
  12. Article
  13. Review
  14. Article
  15. Article
  16. Article
  17. Article
  18. Article
  19. Article
  20. Article

53 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors at 1 institution in 1 country.

Anna BerounBRAINCITY, Nencki Institute, Pasteura 3, 02-093, Warsaw, Poland.
Shiladitya MitraBRAINCITY, Nencki Institute, Pasteura 3, 02-093, Warsaw, Poland.
Piotr MichalukBRAINCITY, Nencki Institute, Pasteura 3, 02-093, Warsaw, Poland.
Barbara PijetBRAINCITY, Nencki Institute, Pasteura 3, 02-093, Warsaw, Poland.
Marzena StefaniukBRAINCITY, Nencki Institute, Pasteura 3, 02-093, Warsaw, Poland.
Leszek KaczmarekBRAINCITY, Nencki Institute, Pasteura 3, 02-093, Warsaw, Poland. l.kaczmarek@nencki.gov.pl.
Instytut Biologii Doświadczalnej im. Marcelego Nenckiego · PL

Funding

Foundation for Polish Science BRAINCITY
6 · The paper itself

Abstract

Matrix metalloproteinases (MMPs) are a group of over twenty proteases, operating chiefly extracellularly to cleave components of the extracellular matrix, cell adhesion molecules as well as cytokines and growth factors. By virtue of their expression and activity patterns in animal models and clinical investigations, as well as functional studies with gene knockouts and enzyme inhibitors, MMPs have been demonstrated to play a paramount role in many physiological and pathological processes in the brain. In particular, they have been shown to influence learning and memory processes, as well as major neuropsychiatric disorders such as schizophrenia, various kinds of addiction, epilepsy, fragile X syndrome, and depression. A possible link connecting all those conditions is either physiological or aberrant synaptic plasticity where some MMPs, e.g., MMP-9, have been demonstrated to contribute to the structural and functional reorganization of excitatory synapses that are located on dendritic spines. Another common theme linking the aforementioned pathological conditions is neuroinflammation and MMPs have also been shown to be important mediators of immune responses.

Indexed as

LearningAnimalsBrainEpilepsyHumansMatrix MetalloproteinasesMemoryMental DisordersNeuronal PlasticityTissue Inhibitor of MetalloproteinasesMatrix MetalloproteinasesTissue Inhibitor of MetalloproteinasesAddictionAutismBehavioral trainingEpilepsySchizophrenia

Identifiers

PMID31172215
PMCPMC6647627
OpenAlexW2954884521

What Socratic holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.